Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc.
Your view on MHTX
Overview
What the company does, where it operates, and who runs it.
About Manhattan Scientifics, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Emmanuel Tsoupanarias
- Headquarters
- 244 Fifth Avenue, New York City, NY, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Emmanuel Tsoupanarias
- Headquarters
- 244 Fifth Avenue, New York City, NY, US
Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine.
The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Manhattan Scientifics, Inc., and the rating behind it. MHTX last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Manhattan Scientifics, Inc.. Starting points for Manhattan Scientifics, Inc.: beta 9.63 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Manhattan Scientifics, Inc.. Manhattan Scientifics, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Manhattan Scientifics, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Manhattan Scientifics, Inc.. Manhattan Scientifics, Inc. has reported as a listed company since 1998. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Manhattan Scientifics, Inc. valued side by side against its closest peers. Manhattan Scientifics, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Manhattan Scientifics, Inc., and how their positions are changing. At a $55,928 market value, institutional positions materially move Manhattan Scientifics, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Manhattan Scientifics, Inc. executives and directors. Shares of Manhattan Scientifics, Inc. have traded between $0.0001 and $0.0010 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Manhattan Scientifics, Inc.. Manhattan Scientifics, Inc. is a $55,928 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Manhattan Scientifics, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Manhattan Scientifics, Inc.. Coverage tracks Manhattan Scientifics, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.